Kathleen M Miller

Title: The Innovative Contributions of Kathleen M. Miller

Introduction

Kathleen M. Miller is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of radiopharmaceuticals, holding a total of 3 patents. Her work focuses on the stabilization of peptides and proteins, which is crucial for the development of effective diagnostic and therapeutic applications.

Latest Patents

One of her latest patents involves the stabilization of peptides and proteins for radiopharmaceutical use. This innovation utilizes surfactants, either alone or in combination with salts, to enhance the stability of radiolabeled peptides and proteins in diagnostic or therapeutic compositions. Another notable patent addresses the use of gentisic acid and its derivatives, which substantially inhibit peptide autoradiolysis. This patent highlights the potential of gentisic acid, either alone or in combination with other stabilizers such as inositol and ascorbic acid, to prevent autoradiolysis of radiolabeled peptides.

Career Highlights

Throughout her career, Kathleen has worked with notable companies, including Mallinckrodt, Inc. and Mallinckrodt Medical, Inc. Her expertise in the field has allowed her to contribute to advancements in radiopharmaceutical technology, making her a valuable asset in the industry.

Collaborations

Kathleen has collaborated with esteemed colleagues such as Edward A. Deutsch and Wilhelmus T. Goedemans. These partnerships have further enriched her work and expanded the impact of her innovations.

Conclusion

Kathleen M. Miller's contributions to the field of radiopharmaceuticals demonstrate her commitment to innovation and excellence. Her patents and collaborations reflect her significant role in advancing medical technology.